<DOC>
	<DOC>NCT00533351</DOC>
	<brief_summary>This study will explore the safety and efficacy of AGN201781 in patients with postherpetic neuralgia or post-traumatic peripheral neuralgia</brief_summary>
	<brief_title>Safety and Efficacy of AGN201781 in Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<criteria>Diagnosis of postherpetic neuralgia or posttraumatic peripheral neuralgia Moderate or severe pain associated with postherpetic neuralgia or posttraumatic peripheral neuralgia Women of childbearing potential Any other uncontrolled diseases</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>